|
US5955107A
(en)
*
|
1997-12-12 |
1999-09-21 |
Fmc Corporation |
Pharmaceutical suspension tablet compositions
|
|
IT1301966B1
(it)
*
|
1998-07-30 |
2000-07-20 |
Zambon Spa |
Composizioni farmaceutiche ad attivita' analgesica
|
|
US20030026835A1
(en)
*
|
1999-02-15 |
2003-02-06 |
Sumitomo Pharmaceuticals Company Limited |
Tablets disintegrating rapidly in the oral cavity
|
|
US6368618B1
(en)
|
1999-07-01 |
2002-04-09 |
The University Of Georgia Research Foundation, Inc. |
Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
|
|
NZ508292A
(en)
*
|
1999-11-24 |
2002-08-28 |
Mcneil Ppc Inc |
Treatment of migraine symptoms with ibuprofen and salts thereof
|
|
KR100523242B1
(ko)
*
|
2000-05-18 |
2005-10-24 |
한미약품 주식회사 |
이부프로펜을 함유하는 정제 조성물
|
|
AU2002255190A1
(en)
*
|
2001-04-10 |
2002-10-28 |
Fakhreddin Jamali |
Composition for enhanced absorption of nsaids
|
|
CH693586A8
(de)
*
|
2002-10-14 |
2003-12-15 |
Roche Consumer Health Ag |
Darreichungsform von Ibuprofen-Natrium.
|
|
EP1585500B8
(en)
*
|
2002-12-20 |
2017-07-26 |
Auritec Pharmaceuticals |
Coated particles for sustained-release pharmaceutical administration
|
|
US20040176234A1
(en)
*
|
2003-03-07 |
2004-09-09 |
Baker Hughes Incorporated |
Method for improving separation operation of centrifuges and associated improved separation designs
|
|
US20080020042A1
(en)
*
|
2003-10-14 |
2008-01-24 |
Peter Gruber |
Dosage form of sodium ibuprofen
|
|
UY28583A1
(es)
*
|
2003-10-30 |
2005-05-31 |
Roche Consumer Health Ag |
Forma de presentación del naproxeno sodico
|
|
US20050266031A1
(en)
*
|
2004-05-25 |
2005-12-01 |
Jay Dickerson |
Pharmaceutical suspension composition
|
|
EP3216445A1
(en)
*
|
2004-05-28 |
2017-09-13 |
Imaginot Pty Ltd. |
Oral therapeutic compound delivery system
|
|
US8216610B2
(en)
*
|
2004-05-28 |
2012-07-10 |
Imaginot Pty Ltd. |
Oral paracetamol formulations
|
|
PL1916994T3
(pl)
*
|
2004-06-29 |
2014-05-30 |
Takeda Pharma As |
Wytwarzanie kompozycji farmaceutycznej o szybkim uwalnianiu leków nierozpuszczalnych w wodzie i kompozycje farmaceutyczne otrzymywane sposobem według wynalazku
|
|
JP2008509207A
(ja)
*
|
2004-08-12 |
2008-03-27 |
レキット ベンキーザー ヘルスケア （ユーケイ） リミテッド |
溶融押出しにより作製するパラセタモール、ｎｓａｉｄ及び糖アルコールを含む顆粒
|
|
US20070077297A1
(en)
|
2004-09-30 |
2007-04-05 |
Scolr Pharma, Inc. |
Modified release ibuprofen dosage form
|
|
US20060068009A1
(en)
*
|
2004-09-30 |
2006-03-30 |
Scolr Pharma, Inc. |
Modified release ibuprofen dosage form
|
|
CN101068532B
(zh)
*
|
2004-09-30 |
2012-03-14 |
斯科尔医药公司 |
布洛芬改进释放剂型
|
|
WO2006056042A1
(en)
*
|
2004-11-03 |
2006-06-01 |
Equitech Corporation |
Nsaid compositions exhibiting clinical superiority
|
|
ES2523988T3
(es)
*
|
2005-02-09 |
2014-12-03 |
Boehringer Ingelheim International Gmbh |
Comprimidos recubiertos que contienen lisinato de ibuprofeno
|
|
PT2559430E
(pt)
|
2005-03-22 |
2015-10-09 |
Stada Arzneimittel Ag |
Ibuprofeno solubilizado
|
|
EP1800667A1
(en)
|
2005-12-23 |
2007-06-27 |
Losan Pharma GmbH |
Rapidly solubilizing ibuprofen granulate
|
|
US20080269334A1
(en)
*
|
2005-09-19 |
2008-10-30 |
Albemarle Corporation |
Highly Concentrated Pourable Aqueous Solutions Of Potassium Ibuprofen, Their Preparation And Their Use
|
|
US7811604B1
(en)
|
2005-11-14 |
2010-10-12 |
Barr Laboratories, Inc. |
Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
|
|
CA2629904C
(en)
|
2005-11-28 |
2018-07-10 |
Imaginot Pty Ltd. |
Oral therapeutic compound delivery system
|
|
KR101288924B1
(ko)
*
|
2006-08-16 |
2013-07-24 |
에스에스 세야쿠 가부시키 가이샤 |
경구투여용 제제
|
|
US8951562B2
(en)
|
2006-11-10 |
2015-02-10 |
Atacama Labs Oy |
Method and apparatus or dry granulation
|
|
FI20070521A7
(fi)
*
|
2006-11-10 |
2008-05-11 |
Atacama Labs Oy |
Rakeita, tabletteja ja rakeistusmenetelmä
|
|
FI20080348A0
(fi)
*
|
2008-02-15 |
2008-05-09 |
Atacama Labs Oy |
Uudenlainen farmaseuttinen formulaatio
|
|
US7749537B2
(en)
|
2006-12-04 |
2010-07-06 |
Scolr Pharma, Inc. |
Method of forming a tablet
|
|
WO2008079245A2
(en)
*
|
2006-12-20 |
2008-07-03 |
Duramed Pharmaceuticals, Inc. |
Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
|
|
WO2009135946A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Atacama Labs Oy |
Method and apparatus for dry granulation
|
|
US9629809B2
(en)
*
|
2008-07-21 |
2017-04-25 |
Si Group, Inc. |
High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
|
|
US9629806B2
(en)
|
2008-07-21 |
2017-04-25 |
Si Group, Inc. |
High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
|
|
EP2323976A4
(en)
*
|
2008-08-14 |
2014-07-02 |
Shasun Chemicals And Drugs Ltd |
ARYLALKYLCARBOXYLIC ACID SALTS, PROCESS FOR PREPARATION THEREOF AND GALENIC FORMS
|
|
AU2015264861C1
(en)
*
|
2009-06-22 |
2017-11-16 |
Pf Consumer Healthcare 1 Llc |
Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
|
|
AU2014200704C1
(en)
*
|
2009-06-22 |
2018-12-06 |
Pf Consumer Healthcare 1 Llc |
Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
|
|
TWI504393B
(zh)
*
|
2009-06-22 |
2015-10-21 |
惠氏有限責任公司 |
製備包含異丁苯丙酸鈉之醫藥組合物之方法
|
|
JP5974469B2
(ja)
*
|
2010-12-24 |
2016-08-23 |
ライオン株式会社 |
錠剤の製造方法
|
|
CN103102259B
(zh)
*
|
2011-12-23 |
2014-02-26 |
海南正瑞医药科技开发有限公司 |
一种布洛芬水合物晶体、及含该水合物晶体的药物组合物及其制备方法
|
|
WO2015016256A1
(ja)
*
|
2013-07-30 |
2015-02-05 |
ライオン株式会社 |
錠剤
|
|
EP2845850A1
(en)
|
2013-09-10 |
2015-03-11 |
ObsEva S.A. |
Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
|
|
EP2886107A1
(en)
*
|
2013-12-17 |
2015-06-24 |
ObsEva S.A. |
Oral formulations of pyrrolydine derivatives
|
|
EP3753921A1
(en)
|
2014-07-02 |
2020-12-23 |
ObsEva S.A. |
Crystalline (3z,5s)-5-(hydroxymethyl)-1-[(2'-methyl-1,1'-biphenyl-4-yl)carbonyl]pyrrolidin-3-one o-methyloxime useful in methods of treating conditions related to the ot-r activity
|
|
EP2965746B1
(en)
|
2014-07-10 |
2019-03-13 |
Santa Farma Ilaç Sanayi A.S. |
An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
|
|
WO2017060920A1
(en)
*
|
2015-10-05 |
2017-04-13 |
Strides Shasun Limited |
Pharmaceutical compositions
|